1. Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials

    Ariette van Strien, Chief Commercial Officer, Marken, discusses siteless/hybrid clinical trials.

  2. Designing Effective Drug Formulations: Keys to Successful Proof of Concept Services

    Ed Scholtz, Ph.D., Vice President of R&D for UPM Pharmaceuticals explains the company's approach to formulations. 

  3. Meeting the Changing Demands for Sterile-Fill Finish Operations

    Justin Kadis, Business Development for Federal Equipment Company, discusses optimized and error-free fill-finish operations.

  4. Ensuring Confidence in Viral Vector Manufacturing

    Christopher Murphy, Chief Manufacturing Officer and Michael Wourms, Associate Director of Fill Finish for Brammer Bio discuss the company’s viral vector development and manufacturing services.

  5. Building a Robust Supply Chain with Dependable Quality Primary Suppliers

    Drug manufacturers and their suppliers face a number of challenges, such as downward pricing pressures and the need for flexibility and speed to market, says Dale Martin, General Manager & CFO for CapsCanada.

  6. Meeting the Need for Small-Volume API Manufacturing

    Jim Scandura, Executive VP, Chief Operating Officer; Gary Butler, Vice President & Avlon Site Director; and Werner Kunz, Vice President & Shannon Site Director at Avara Pharmaceutical Services explain the integrated API service offering.  

  7. FDA Gives De Novo Clearance to First Over-the-Counter Hearing Aid

    The Bose Hearing Aid gives similar results with self-fitting to hearing aids fitted by a health provider.

  8. Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

    This is the first Microsoft partner focused in the microbiome genomics market.

  9. New Study Examines How Pharmaceutical Industry is Embracing Digital Patient Engagement Programs

    Patient engagement programs built around digital tools have quickly taken hold in leading pharmaceutical, biotechnology and medical device organizations across global, emerging and developed markets.

  10. PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections

    Study to enroll up to 300 patients; with top-line results expected in the second half of 2019.

  11. Continuing on the Acquisition Trail: Building Out a World-Class, Customer-Oriented CDMO

    Tim Tyson, Chairman and CEO of Avara Pharmaceutical Services, discusses the company's acquisition strategy.

  12. Facilitating Implementation and Customer Service with Offline Serialization

    Tyler Ewald, Associate Director, Manufacturing and Joseph Quales, Supervisor, Label Control at UPM Pharmaceuticals explain the company’s offline serialization system.

  13. Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing

    Richard Snyder, Ph.D., Chief Scientific Officer and Founder; Christopher Murphy, Chief Manufacturing Officer; Susan D'costa, VP Development and Cameron Jones, Quality Assurance Director at Brammer Bio explain how to strengthen security of supply in viral vector manufacturing.

  14. Transforming with an Equipment Partner: Preparing the Industry for Serialization

    Justin Kadis, Business Development for Federal Equipment Company explains the link between the serialization mandate and pharma equipment. 

  15. Optimizing Profitability in Drug Product Manufacturing with Hard-Shell Capsules

    Steve Lee, Technical Service Manager, CapsCanada, explains cost savings with hard-shell capsules.

  16. Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services
    Janice Graff, Director of Finished Product Sales & Business Development and KaShauna G. Rohlehr PMP, Program Manager at GSK Contract Manufacturing explain the company’s commitment and expertise in the development and commercialization of novel biotherapies.
  17. New Collaboration Aimed at Improving Cancer Diagnostics in the UK

    IQVIA and Genomics England will be offering a new solution for researchers to develop custom clinical–genomic data sets.

  18. Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns

    The latest award will provide support for pediatric studies related to the company's StrataGraft® viable, engineered skin tissue. 

  19. GHIT Fund Welcomes Ono Pharmaceutical Co., Ltd. as New Funding Partner

    With the addition of Ono, GHIT now counts 21 public and private organizations as funding partners.

  20. UK Hospital to Get Command Center Driven by AI and Real-Time Analytics

    GE Healthcare contracted to build at a UK National Health Service (NHS) teaching hospital.

Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
SEARCH COMPANIES
FDA

FDA Gives De Novo Clearance to First Over-the-Counter Hearing Aid

Oct 16, 2018 11:59:49 AM PAO-M10-18-NI-015
Diagnostics

New Collaboration Aimed at Improving Cancer Diagnostics in the UK

Oct 16, 2018 11:57:19 AM PAO-M10-18-NI-014
Artificial Intelligence

UK Hospital to Get Command Center Driven by AI and Real-Time Analytics

Oct 16, 2018 11:53:40 AM PAO-M10-18-NI-013
Clinical Trials

New Diabetes Drug Shows Promise in Phase 2 Study

Oct 16, 2018 11:46:31 AM PAO-M10-18-NI-012
Investment

GSK Funds British Biotech Sitryx

Oct 16, 2018 11:26:15 AM PAO-M10-18-NI-011
Clinical Trials

New Clinical Trial Will Evaluate Biomarkers as Predictors of Treatment Response in IBD

Oct 12, 2018 2:22:42 PM PAO-M10-18-NI-009
RNA

Janssen Collaborates on RNA Therapy

Oct 11, 2018 2:28:39 PM PAO-M10-18-NI-008
Speed to Market

Product and Service Concepts Driving Speed to Market

Oct 8, 2018 11:48:41 AM PAO-M10-18-CL-001
Columns

Nice Insight Overview

Patient Centricity and the Pharmaceutical Supply Chain: An Evolving Dynamic
Becoming a true patient-centric industry requires significant effort and a complete change in the way pharmaceutical companies operate.

Outsourcing Solutions

Leveraging Offsite Fabrication in the Pharma Industry

Investment Watch

The Biotech Boom
Emilie Branch, Strategic Content Manager, Nice Insight
Biotech IPOs are commanding a larger market share than the year before — and this trend shows no signs of slowing down.

Regulatory Spotlight

Competitive Generic Therapy: A New Patient-Centric FDA Pathway

David Alvaro, Ph.D., Scientific Editorial Director, Nice Insight